Edition:
United States

Opexa Therapeutics Inc (OPXA.OQ)

OPXA.OQ on NASDAQ Stock Exchange Capital Market

0.66USD
26 May 2017
Change (% chg)

$0.01 (+1.85%)
Prev Close
$0.65
Open
$0.68
Day's High
$0.68
Day's Low
$0.61
Volume
24,736
Avg. Vol
45,265
52-wk High
$4.92
52-wk Low
$0.50

OPXA.OQ

Chart for OPXA.OQ

About

Opexa Therapeutics, Inc. (Opexa) is a biopharmaceutical company. The Company is engaged in the development of a personalized immunotherapy with the potential to treat various illnesses, including multiple sclerosis (MS), as well as other autoimmune diseases, such as neuromyelitis optica (NMO). These therapies are based on its... (more)

Overall

Beta: 1.90
Market Cap(Mil.): $5.05
Shares Outstanding(Mil.): 7.66
Dividend: --
Yield (%): --

Financials

  OPXA.OQ Industry Sector
P/E (TTM): -- 137.90 17.41
EPS (TTM): -0.95 -- --
ROI: -136.97 -8.48 -5.42
ROE: -136.97 -11.31 -4.68

BRIEF-Opexa Therapeutics quarterly loss per share $0.12

* Opexa Therapeutics Inc - cash and cash equivalents were $2.8 million as of March 31, 2017, compared to $3.4 million as of December 31, 2016

May 12 2017

More From Around the Web

Earnings vs. Estimates